WUXI06:BKK
Wuxi Biologics (Cayman) Inc. KKPS DR
5,20 THB
0,00%
(0,00) 1 d
15 okt., 16:40:00 GMT+7 · THB
search
Alla symboler
| Symbol | Pris | Ändring | Ändring i procent |
|---|
insights_autoGenererar de viktigaste insikterna för WUXI06 …
Öppen
5,25 THB
Högt
5,35 THB
Lågt
5,05 THB
Börsvärde
198,43 md
Genomsn. vol.
93,60 tn
Volym
288,50 tn
52v högst
6,25 THB
52v lägst
3,02 THB
Utestående aktier
4,12 md
Antal anställda
15 tn
Öppen
5,25 THB
Högt
5,35 THB
Lågt
5,05 THB
Börsvärde
198,43 md
Genomsn. vol.
93,60 tn
Volym
288,50 tn
52v högst
6,25 THB
52v lägst
3,02 THB
Utestående aktier
4,12 md
Antal anställda
15 tn
Nyheter och artiklar
Från webbkällor och nyhetspartner
Vietnam.vn
·
för 1 dag sedan
Snabbläsning 16-10: Dow Jones stiger över 550 poäng då obligationsräntorna faller, PV Power uppskattar 9-månaders vinst till över 5 400 miljarder VND
HurBra.se
·
för 20 timmar sedan
USA-börsen 15 oktober 2026: Vård lyfte, AI pressades
Vietnam.vn
·
för 2 dagar sedan
Snabbläsning 15-10: S&P 500 drabbas av största fallet sedan juli efter inflationsdata, PV GAS 9-månaders vinst nästan fördubblar årsmålet.
Law360
·
för 1 timme sedan
Nasdaq Sued Over Delisting Of Social Media Co.
Profil
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, when it was founded as a division of WuXi AppTec and began building out capabilities and facilities required for biologics discovery, development and good manufacturing practices. After being spun off from its parent, WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Om Wuxi Biologics (Cayman) Inc. KKPS DR